Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Comprehensive Genetic Characterization of 63 Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFR-α, PDGFR-β, FGFR1 or PCM1-JAK2

Constance Regina Baer, PhD, Verena Muehlbacher, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 4219.

https://doi.org/10.1182/blood.V130.Suppl_1.4219.4219

Published: 2017

Journal Articles

Detection of ABL1 kinase Domain Mutations in Therapy Naive BCR-ABL1 Positive ALL

Constance Regina Baer, PhD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 3972.

https://doi.org/10.1182/blood.V130.Suppl_1.3972.3972

Published: 2017

Journal Articles

Mutation Screening at Diagnosis Reveals a High Frequency of ASXL1 Mutations in CML Patients Who Fail to Achieve Molecular Remission Criteria after One Year of TKI Treatment

Constance Regina Baer, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 1585.

https://doi.org/10.1182/blood.V130.Suppl_1.1585.1585

Published: 2017

Journal Articles

The Use of Unique Molecular Identifiers (UMIs) Strongly Improves Sequencing Detection Limits Allowing Earlier Detection of Small TP53 Mutated Clones in Leukemias

Constance Regina Baer, PhD, Niroshan Nadarajah, M.Sc., Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2016) 128 (22): 2027.

https://doi.org/10.1182/blood.V128.22.2027.2027

Published: 2016

Journal Articles

In CLL with Normal Karyotype By Conventional and Genomic Array Karyotyping the Prognostic Impact of an Unmutated IGHV Status Is Stronger Than the Impact of Gene Mutations

Calogero Vetro, MD, Torsten Haferlach, MD, Manja Meggendorfer, PhD, Sabine Jeromin, PhD, Constance Regina Baer, PhD, Niroshan Nadarajah, M.Sc., Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2016) 128 (22): 4357.

https://doi.org/10.1182/blood.V128.22.4357.4357

Published: 2016

Journal Articles

A Study on Paired Tissue Sequencing in Hematologic Diseases to Distinguish Somatic from Germline Sequence Variants in Routine Diagnostics

Constance Regina Baer, PhD, Niroshan Nadarajah, M.Sc., Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2016) 128 (22): 5511.

https://doi.org/10.1182/blood.V128.22.5511.5511

Published: 2016

Journal Articles

Prospective Next-Generation Sequencing of Mutations in the ABL1 Kinase Domain in CML Patients Lacking Optimal Response According to ELN Guidelines

Constance Regina Baer, PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2016) 128 (22): 3100.

https://doi.org/10.1182/blood.V128.22.3100.3100

Published: 2016

Journal Articles

Characterization of MYD88 mutated Lymphoplasmacytic Lymphoma in Comparison to MYD88 mutated Chronic Lymphocytic Leukemia

Constance Regina Baer, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Torsten Haferlach, Claudia Haferlach, MD

Blood (2015) 126 (23): 132.

https://doi.org/10.1182/blood.V126.23.132.132

Published: 2015

Journal Articles

Myelodysplastic Syndrome Patients Show Mutation-Specific DNA Methylation Patterns

Constance Regina Baer, PhD, Niroshan Nadarajah, M.Sc., Yasunobu Nagata, MD, Tamara Alpermann, Genta Nagae, MD PhD, Yusuke Okuno, MD PhD, Yuichi Shiraishi, MD PhD, Satoru Miyano, MD PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Hiroyuki Aburatani, MD PhD, Seishi Ogawa, MD PhD, Torsten Haferlach

Blood (2015) 126 (23): 1646.

https://doi.org/10.1182/blood.V126.23.1646.1646

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Comprehensive Genetic Characterization of 63 Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFR-α, PDGFR-β, FGFR1 or PCM1-JAK2

Detection of ABL1 kinase Domain Mutations in Therapy Naive BCR-ABL1 Positive ALL

Mutation Screening at Diagnosis Reveals a High Frequency of ASXL1 Mutations in CML Patients Who Fail to Achieve Molecular Remission Criteria after One Year of TKI Treatment

The Use of Unique Molecular Identifiers (UMIs) Strongly Improves Sequencing Detection Limits Allowing Earlier Detection of Small TP53 Mutated Clones in Leukemias

In CLL with Normal Karyotype By Conventional and Genomic Array Karyotyping the Prognostic Impact of an Unmutated IGHV Status Is Stronger Than the Impact of Gene Mutations

A Study on Paired Tissue Sequencing in Hematologic Diseases to Distinguish Somatic from Germline Sequence Variants in Routine Diagnostics

Prospective Next-Generation Sequencing of Mutations in the ABL1 Kinase Domain in CML Patients Lacking Optimal Response According to ELN Guidelines

Characterization of MYD88 mutated Lymphoplasmacytic Lymphoma in Comparison to MYD88 mutated Chronic Lymphocytic Leukemia

Myelodysplastic Syndrome Patients Show Mutation-Specific DNA Methylation Patterns

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only